info@seagull-health.com
SeagullHealth
语言:
search

Who can use Cibinqo(abrocitinib)?

CIBINQO is indicated for adults with refractory moderate-to-severe atopic dermatitis whose disease is not adequately controlled with other systemic medications (including biologics) or for whom these therapies are not appropriate.

Cibinqo(abrocitinib)
Cibinqo(abrocitinib)
Adults with refractory moderate-to-severe atopic dermatitis.
WeChat Scan
Free Inquiry
Related articles
共 0 条
  • 1
前往
New Drugs
Infigratinib(Truseltiq)
Infigratinib(Truseltiq)
Treatment of previously treated, unresectable locally advanced or metastatic...
Opicapone(Ongentys)
Opicapone(Ongentys)
Adjunctive treatment to levodopa/carbidopa for reducing "off" episodes in...
Deflazacort(Emflaza)
Deflazacort(Emflaza)
Treatment of Duchenne muscular dystrophy (DMD) in patients aged 2 years and...
Faricimab-svoa(Vabysmo)
Faricimab-svoa(Vabysmo)
Treatment of neovascular age-related macular degeneration, diabetic macular...
Counselling Service
Global Drug Search
Clinical Research Recruitment
Overseas Medical Treatment
Remote Consultations
Note: Our medical consultant will contact you as soon as possible. We promise to strictly protect your privacy.
Submit
Business
  • Core products
  • Antitumor drugs
  • General drug
  • Antiviral drugs
  • Biological agents
Contact Us 
  • haiousales@gmail.com
Welcome to consult
Seagull Pharmacy.,Ltd All rights reserved